# CNPLE Cram V2 — Parity Batch 40A Clinical Second Pass

Date: 2026-08-09
Scope: `40a-neurology-high-yield-parity.json`
Result: **PASS — clinical authoring second pass**

## Exact identity contract

All ten records use literal `np-${slugify(concept)}` identities from the canonical NP parity generator:

- `np-migraine-prophylaxis-and-abortive-therapy`
- `np-seizure-classification-and-antiepileptic-selection`
- `np-tia-workup-and-risk-stratification`
- `np-parkinson-disease-diagnosis-and-management`
- `np-essential-tremor-evaluation-and-treatment`
- `np-multiple-sclerosis-diagnosis-and-disease-modifying-therapy`
- `np-peripheral-neuropathy-workup-and-management`
- `np-dementia-diagnosis-and-disease-modifying-therapy`
- `np-delirium-recognition-and-management`
- `np-meningitis-and-encephalitis-recognition`

## Clinical second-pass findings

- Migraine: secondary-headache red flags remain upstream of routine therapy; prevention is disability/frequency/acute-medication-burden driven and agent selection is individualized.
- Seizure: classification precedes ASM choice; provoked seizure is not automatically epilepsy; reproductive and interaction risks are explicit.
- TIA: resolved symptoms remain urgent; imaging/mechanism evaluation is not replaced by a risk score.
- Parkinson disease: bradykinesia is required for the syndrome; medication timing/continuity, atypical features and nonmotor care are explicit.
- Essential tremor: action/postural phenotype is separated from parkinsonism and therapy is function-goal driven.
- MS: true relapse is separated from infection/heat-driven pseudo-relapse; DMT monitoring is agent-specific and pregnancy planning is explicit.
- Peripheral neuropathy: distribution/tempo precedes laboratory testing; rapid motor/autonomic patterns escalate.
- Dementia: delirium is excluded first; function/capacity/safety and caregiver planning are integral; disease-modifying Alzheimer therapy is specialist/stage/biomarker specific.
- Delirium: cause correction and nonpharmacologic safety are primary; asymptomatic bacteriuria and routine sedation are rejected.
- Meningitis/encephalitis: diagnostics do not create a harmful empiric-antimicrobial/acyclovir delay in a strongly suspected deteriorating CNS infection syndrome.

## Canadian source refresh

Load-bearing resources rechecked 2026-08-09:

- Canadian Stroke Best Practices — TIA/minor stroke triage and acute stroke management.
- Choosing Wisely Canada Neurology/Emergency Medicine — avoid low-value routine neuroimaging/EEG in simple syncope and established uncomplicated epilepsy contexts.
- Parkinson Canada — individualized medication treatment and medication-timing safety in health-care settings.
- MS Canada — Health Canada-approved DMT landscape, individualized risk/benefit choice and treatment-monitoring requirements.
- Canadian Headache Society migraine guidance and Canadian neurologic practice principles.

## Publication boundary

Clinical authoring PASS only. Structural parse/global uniqueness, exact-current-Full reconciliation, point/Bottom-Line anchors, three eligible Quick Checks, runtime integrity and learner render certification remain private-core fail-closed gates.
